Showing posts with label animal research information. Show all posts
Showing posts with label animal research information. Show all posts

Saturday, September 25, 2010

NOT IN OUR NAME: ANIMAL DEFENDERS INTERNATIONAL CALLS FOR A GLOBAL STAND AGAINSTSPACE EXPERIMENTS ON ANIMALS

AND CALLS ON THE PUBLIC TO PROTEST TO THE US & RUSSIAN EMBASSIES

LONDON, Sept 24, 2010 -- Animal Defenders International (ADI), the leading animal welfare organisation that works globally for the protection of animals, has launched a major international drive to stop NASA and the Russian Federal Space Agency (Roscosmos) from performing radiation experiments on monkeys as part of plans to travel to mars.

The ADI offices in Los Angeles have instigated a campaign in Congress to halt the NASA experiments and the London headquarters of ADI are co-ordinating a global drive urging people to contact the US and Russian Embassies.

The campaign has attracted the backing of astronauts, former NASA employees, and a commitment from the European Space Agency not to perform monkey experiments.

At the heart of the new campaign is a compelling 4-minute video entitled 'Space Experiments on Monkeys - One Giant Leap Backwards' which recaps the prior use of animals in space research, cites reasons NASA's irradiation experiments are flawed and premature, and presents viable alternatives to primate testing. The DVD also includes an exclusive ten-minute interview with April Evans, former NASA engineer who explains she resigned her dream job with one of the world's top space agencies because of NASA's radiation tests. Both videos are also being launched online as part of a major awareness drive.

Every member of the US Congress will receive a copy of the DVD and copies will be sent to the US and Russian Embassies around the world.

Tim Phillips, Animal Defenders International Campaign Director said, "These tests are cruel, unnecessary, premature and a waste of $1.75 US million of taxpayers' money. Our video shows that these monkey experiments have been criticised from every side, scientists, animal protectionists, astronauts, former NASA employees, and even the European Space Agency. We are not opposed to space exploration, but these experiments are cruel folly."

The video reveals the horrific nature of the monkey experiments which will include: Burns, weakness, hair loss, failing organs and nausea. It also points out that there are already a significant number of sources for data on the impacts of high doses of radiation on humans including the victims of atomic bombs, X-rays and radiotherapy, the nuclear power industry, and astronauts who have spent time in space.

Tim Phillips said: "Those in the space programme often talk in lofty terms that this is about making advances for the whole of humankind. We want the world to make it clear that this cruelty is not in our name, and there are plenty of people in the space research community who agree with us."

Cosmonaut Valentin Lebedev, who set a world record for time in space, describes the tests as "inadmissible for humane reasons" citing the wealth of data available from astronauts.

Jim Bates, NASA retired, formerly Co-Chairman of the JSC Space Radiation Environment Group (SREG) 1968-1970, has noted the decades of similar experiments on animals and said: "We have probably sacrificed enough monkeys for these data, something else is needed."

The European Space Agency's (ESA) Director Jean-Jacques Dordain stated that he and ESA categorically opposed and "declines any interest in monkey research and does not consider any need or use for such results." The statement confirms the unnecessary character of NASA's tests and reveals the uneasiness of a large segment of the scientific community involved in space research about the use of monkeys in experiments.

Tim Phillips said: "These experiments are wrong every way that you look at them. There is a wealth of data available and alternatives which include cell and tissue culture study, the simulated human torso in space, and the use of scanning techniques to examine neurological function in patients undergoing partial brain radiotherapy. Even if you ignore all of this, NASA does not yet have the shielding technology to protect the astronauts on such a mission, and this would determine any type radiation exposure, so these tests are shamefully premature."

Aerospace engineer April Evans resigned her position earlier this year as a space architect on the International Space Station (ISS) program because of NASA's decision to conduct primate irradiation testing. Evans believes this experiment is a major step backward for NASA's animal testing record.

"After much deliberation, I resigned from NASA because I could not support the scientific justification for this monkey radiobiology experiment," Evans wrote in a letter to Samuel Aronson, director of the Brookhaven National Laboratory, which was contracted by NASA to conduct the tests on squirrel monkeys.

"NASA needs to focus on developing space radiation shielding because both astronauts and hardware are at risk from the space radiation environment, an issue that will have to be addressed by all space agencies. Space vehicle radiation shielding is necessary technology for a sustainable long-term human space exploration program and scientists and engineers should be given the chance and time to advance shielding technology."

For more information on the campaign, visit: www.ad-international.org/NASA where you can view and download the videos and join in the fight to stop NASA's planned experiments.

Please address polite letters to NASA requesting that they reconsider financing such horrific experiments by writing to NASA Administrator Charles F. Bolden Jr, Public Communications Office, NASA Headquarters, Suite 5K39,Washington, DC, 20546-0001

Please write to the US Ambassador saying you oppose the NASA experiments: Mr Louis B. Susman, US Embassy, 24 Grosvenor Square, London, W1A 1AE.

Please write to the Russian Ambassador saying you oppose Russia's Mars500 experiments: Mr Yury Fedotov, Ambassador of the Russian Federation, 13 Kensington Gardens, London W8 4QX.

About Animal Defenders International (ADI):

With offices in London, Los Angeles, and Bogota, Animal Defenders International (ADI) campaigns to protect animals in entertainment; replacement of animals in experiments; worldwide traffic in endangered species; vegetarianism; factory farming; pollution and conservation. ADI also rescues animals in distress worldwide. ADI-gathered evidence has led to campaigns and legislative action all over the world to protect them.
ADI's Mission: To educate, create awareness, and promote the interest of humanity in the cause of justice, and the suppression of all forms of cruelty to animals wherever possible to alleviate suffering, and to conserve and protect animals and the environment.

www.adiusa.org

http://www.ad-international.org/adi_world/


Note to the editors
The White House statement on radiation shielding President Barack Obama declared in April 15, 2010: "after decades of neglect, we will increase investment -- right away -- in other groundbreaking technologies that will allow astronauts to reach space sooner and more often, to travel farther and faster for less cost, and to live and work in space for longer periods of time more safely. That means tackling major scientific and technological challenges. How do we shield astronauts from radiation on longer missions? How do we harness resources on distant worlds? How do we supply spacecraft with energy needed for these far-reaching journeys? These are questions that we can answer and will answer."
The full speech is available here:

http://www.nasa.gov/news/media/trans/obama_ksc_trans.html

# # #

Media Contact: Phil Buckley, Media Relations Director, Animal Defenders International, 0207 630 3344, 07716 018250, prdesk@ad-international.org

Sunday, November 1, 2009

Undercover investigation exposes shocking animal cruelty and major failings by the UK government

The BUAV, one of the world's leading organisations campaigning to end animal experiments, has today revealed graphic disturbing evidence of the cruelty and suffering inflicted on thousands of animals every year in UK research; including for the first time, the appalling suffering inflicted on mice for the worldwide craze of using botox products to temporarily reduce facial lines and wrinkles.

The BUAV has also accused the Home Office, which regulates animal experiments in the UK, of breaking the law in several ways including not enforcing the use of non animal alternatives and failing to minimise the suffering inflicted on animals.

The BUAV placed an undercover worker in Wickham Laboratories in Hampshire for 8 months to the end of October 2009. She secretly filmed the appalling suffering inflicted on thousands of animals inside the facility. The laboratory carries out poisoning tests on thousands of mice every month for a product called Dysport ® (manufactured by Ipsen), which contains the deadly botulinum toxin. Botulinum toxin is licensed in the UK for some relatively rare medical conditions – and the Home Office claims it only allows the animal tests for these purposes - but is increasingly being used “off-label” in cosmetic clinics for purely cosmetic purposes where it is commonly referred to as 'botox.'

In practice it is impossible for the Home Office to ensure that the Dysport ® tested at Wickham on an industrial scale does not end up in cosmetic clinics. The Government has banned animal testing for cosmetics since 1997.

The test used is the archaic poisoning test LD50 (lethal dose 50 - this is the dose at which 50% of the mice would be expected to die when injected with the toxin), one of the cruellest and most controversial tests carried out on animals. Even the Home Office classifies it as 'substantial severity.'

Wickham also uses rabbits in pyrogenicity (fever) tests where a test substance is injected into an ear vein to detect contaminants. The rabbits are restrained by their necks in stocks with a temperature probe deep in their rectum for many hours at a time, with no access to water. According to the laboratory, damage to the ear and rectum can occur as well as damage to the rabbits' backs from struggling in the stocks. Rabbits can be starved for up to 30 hours and are re-used repeatedly in further pyrogen tests, adding to their distress.

Key findings:

The UK government is failing in its legal obligation to enforce the use of the 3R's (Replacement, Reduction and Refinement) principle for non-animal alternatives where they exist and to ensure that, if animals are used, then it should be the minimum number and with the minimum amount of suffering.

The appalling suffering inflicted on thousands of animals in cruel, crude and archaic tests. Animals kept in small, virtually barren cages that failed to meet their behavioural and social needs.

The total inadequacy of measures to intervene before death with the LD50 poisoning tests - far more animals died an agonizing death than were euthanased.

Mice crudely killed by having their necks broken on a corridor floor with a ball point pen. Some staff breaking the backs of mice rather than their necks resulting in excruciating additional suffering.

Some animals suffered in tests that are no longer required by national and international regulations. This destroys the often made claim that companies have to do animals tests because regulators require them.

A glaring conflict of interest by the statutory 'Named Veterinary Surgeon,' responsible for advising on the animals' welfare. He is a director of Wickham and with his wife owns virtually all the shares. Recorded weekly visits by him often lasted just for a few minutes.

Tests such as the LD50 test for botulinum toxin and the pyrogenicity test have valid in vitro alternatives and it is outrageous that they are not being implemented. The Limulus amoebocyte lysate assay (LAL) is an 'in vitro' method that can often be used for detecting bacterial pyrogens and is recognized by regulatory authorities in both Europe and the USA as an alternative to the rabbit pyrogenicity test. Indeed, European guidelines stress the alternative is often more reliable..

The SNAP-25 assay, a method that does not use live animals but instead measures the activity of the toxin in a test tube, can be used to replace the botox mouse LD50 tests. The BUAV believes that under UK law this test should be used. Furthermore, this test has been validated by an official UK government laboratory, the National Institute for Biological Standards and Control (NIBSC), and has been used by them since 1999, specifically for Dysport ®. Inexplicably, the UK Home Office is not insisting on this test even after all these years.

BUAV's Director of Special Projects, Sarah Kite states: “Time and time again the government and animal research community claim that animals are only used as a last resort for vital medical research and that animal suffering is kept to a minimum. This BUAV investigation has blown those claims wide open. Our shocking findings show that crude, archaic and extremely cruel animal tests are still allowed in the UK even when an alternative test exists and animal testing is not required by official bodies.”

For further information, images and video footage, please contact: Sarah Kite

sarah.kite@buav.org

Thursday, October 22, 2009

SAFER MEDICINES CAMPAIGN-THE SAFETY EVALUATION BILL 2009!



ACTION!
Your help in persuading MPs to sign
EDM 569 is vital! A phenomenal 250
MPs signed EDM 92 in 2006, thanks
to your encouragement.
Please help us put pressure on the
Government by achieving even greater
support for EDM 569 – send
our postcard to your MP today
or write to them at: House of Commons,
London SW1A 0AA.
Contact us at the address above for
further copies of this sheet or postcard
To visit the site,read full article and take action:http://www.safermedicines.org/safetyofmedicines/index.shtml
Credit:Viva http://www.viva.org.uk/


Wednesday, October 21, 2009

Two New Books Explore Arguments Against Animal Research

Dr. Ray Greek and Dr. Niall Shanks have published two new books
exploring the scientific reasons using animals to predict human
response to drugs and disease is dangerous and scientifically
untenable.

FAQs About the Use of Animals in Science, breaks down the scientific
argument against vivisection in language non-scientists can understand
and remember. This easy-to –read, easy-to-recall format will help you
answer friends’ and relatives’ questions about vivisection. This is
the book you need in order to intelligently engage in this debate.
Drs. Greek and Shanks explore the fallacies of using animals to study
human disease from an unbiased, scientific perspective; while they do
not discuss the ethics of using animals, the implications are obvious.
FAQs About the Use of Animals in Science takes the necessary out of
necessary evil.

Animal Models in Light of Evolution (Brown Walker) was written for the
science-educated audience. This book is meant for people with
doctorates in some area of science or the very motivated reader. This
book does not simplify the material and expects the reader to be
conversant in evolutionary biology, nonlinear dynamical systems (also
known as complex systems), evo devo, genomics (including gene
expression and regulation), ADMET and drug metabolizing enzymes, as
well as other areas of science. It is available at all the usual
Internet bookstores and from the publisher.

If you would like to interview Dr. Greek or would like him to speak in
your area, please contact him at 805-685-6812 or email at
DrRayGreek@aol.com
For more information about Dr. Shanks and Dr.
Greek or the books or the subject in general, please visit AFMA’s
website at www.curedisease.com

Monday, October 12, 2009

Protest Drug Companies on Columbus Day



Focus: Huntingdon Life Sciences Customers
Sanofi Aventis, Novartis, Bristol-Myers Squibb

Join Win Animal Rights, this Monday, as we turn our attention once again
to the the companies that allow Huntingdon Life Sciences (HLS) to
continue the killing. Right now, Huntingdon Life Sciences (trading on
the NYSE Arca as LSR) is concentrating all of their effort on a
management buyout spearheaded by Andrew Baker, CEO of Huntingdon Life
Sciences.

Regarding Fortress, SHAC UK has re-instated the campaign against
Fortress. This week, we will offer Fortress the opportunity to respond
to SHAC's charges. If proof is not forthcoming quickly, it is likely
that WAR will also reactivate the Fortress campaign. We will keep you
posted.

Huntingdon Life Sciences is a company whose primary business is death
and suffering. 500 animals are killed there every day. Their customers
are the ones that contract and pay for the killing. Without customers,
Huntingdon Life Sciences would go out of business. Join us as we mourn
the 180,000 that die every year at HLS and fight for the ones that are
still alive and waiting to die.

The best way to stop the killing at HLS is to influence their
customers. The companies that we will be visiting on Monday have the
power to discontinue the contracts that allow HLS to torture and kill
animals daily. All of our protests are peaceful and legal. If you are
free on Monday, please consider joining your voice with ours as we
advocate for the poor suffering animals at HLS.

Date: Monday, October 12, 2009 @ 2:00 pm
Where: 90 Park Ave (between 39th & 40th Sts.)
New York City

After the initial protest, we will be walking to other locations in the
general area. Please wear comfortable walking shoes or bring carfare if
you wish to take the bus or train to the next location. Posters,
banners and literature will be provided. Just bring a loud voice and
your dedication to use that voice to speak up for the animals who suffer
in silence.

If you cannot join us, please consider writing to the following:

Sanofi Aventis
90 Park Avenue
New York, NY 10016
Phone: (212) 551-4000

James Cornelius
CEO & Chairman of the Board
Bristol-Myers Squibb
345 Park Ave.
New York, NY 10154
Tel: 1.212.546.4000
james.cornelius@bms.com

residence: 25 Columbus Circle #ST59E, New York, NY 10019

Lamberto Andreotti
President and Chief Operating Officer
Bristol-Myers Squibb
345 Park Ave.
New York, NY 10154
Tel: 1.212.546.4000
lamberto.andreotti@bms.com

residence: 1 W. 64th St., New York, NY 10023

Robert Pelzer
President & CEO
Novartis Pharmaceuticals
608 Fifth Ave.
New York, NY 10020
Tel: 1.212.307.1122
robert.pelzer@novartis.com

residence: 400 E. 51st St. #24B, New York, NY 10022

Please keep all communications with the above polite and informative.
Let them know that abusing and torturing animals is not the right way to
go. A picture may be more convincing. Visit:

http://www.shac.net/HLS/photos.html#photos/2008b.jpg

Coming events: Mark your calendars now!
(Details on many of the listings can be found on the WAR Yahoo Calendar
linked below)

October 17 - 24, 2009: National Primate Liberation Week
Oct. 31, 2009: Halloween Parade - March for Animal Liberation - Parade
& Protests
November 27 - 29 - Fur Free Friday Weekend

Visit the WAR Calendar for future events:
http://calendar.yahoo.com/winanimalrights

Visit the WAR MySpace page: http://www.myspace.com/winanimalrights

Visit WAR on Facebook:
http://www.facebook.com/pages/Win-Animal-Rights/25169195791

For more info contact Win Animal Rights at: winanimalrights@optonline.net

Call: 646.267.9934 or visit the WAR website at: http://war-online.org


W.A.R. (WIN ANIMAL RIGHTS) is an independent non-profit organization not
affiliated or associated with SHAC, SHAC USA or any other group or
organization and does not conduct or incite any illegal activity. The
above information is not meant to incite or request any illegal actions
or illegal activities of any kind. If you have any questions about the
legality of any act, we encourage everyone receiving this (or the)
action alert(s) to check your local laws and ordinances before
proceeding to do anything.

Wednesday, October 7, 2009

EU blasted by campaigners over lab animal cruelty

EU blasted by campaigners over lab animal cruelty - crucial meeting on
12 October

The BUAV has today condemned the EU for ignoring public opinion after a
leaked document shows that the Council of Ministers wants researchers to
have the right to cause suffering to animals in laboratories which is
not only severe but which is also long-lasting. Such a move would result
in untold cruelty and suffering to thousands of animals across Europe.
Only recently a YouGov poll in the UK, Germany, France, Italy, Sweden
and the Czech Republic showed that a resounding 84% believe that
experiments causing severe pain or suffering - i.e. whether or not
long-lasting - should be prohibited.

The leaked document ("Proposal for a Directive of the European
Parliament and of the Council on the protection of animals used for
scientific purposes") from the EU Presidency has been sent to the
Working Party of Veterinary Experts to be discussed at its meeting next
week, 12th October. The document also gives examples of shocking
experiments that researchers want to be allowed to continue to carry out
on animals. They include: poisoning animals to death; submitting animals
to repeated electric shocks from which they cannot escape (in order to
induce 'learned helplessness'); restraining animals to such an extent
that they develop stomach ulcers or heart failure; forcing animals to
swim until they give up in exhaustion; and giving animals a lethal dose
of radiation or chemotherapy.

The animal research industry community acknowledges that these
experiments cause severe suffering but claim, absurdly, that the
suffering is not long-lasting and would therefore not even need special
permission.

The same YouGov poll showed very large majorities wishing to see bans on
the use of primates, dogs and cats in experiments causing suffering, a
ban on all experiments which are not for life-threatening or serious
human conditions; and maximum openness, with only information which is
confidential or would identify individuals or establishments withheld.
Again, EU politicians seem determined to do the exact opposite.

BUAV's Chief Executive, Michelle Thew said: "We are appalled to learn of
the proposals that the Council has made. This is a major step backwards
for animal welfare. It's high time European politicians started
listening to the public rather than the self-interested pleading of the
multi-billion pound animal research and supply industry."

ENDS

Saturday, September 26, 2009

Killing One Primate to Save Another: The Ethics of Animal Rights

A disturbing story emerged this week of a scientist leaving his
research out of fear for his and his family's lives. What are our
responsibilities in this area and what do our traditions have to say
about it?
...
A fire-bomb is left (undetonated) on the porch. Lives and careers
shift. Laws are made and broken. What is it? Religious conflict?
Ideological rifts? Kind of.

In this week's Nature, the scientist Dario Ringach tells the
disturbing story of how, because he did research on primates, he was
targeted for violent treatment by so-called ‘animal rights
extremists’; how after the fire-bomb incident (the bomb was
accidentally left on the wrong scientist’s doorstep), for fear of his
and his family’s safety, he discontinued his animal research; how he
is speaking up now, three years later, because “we’re getting awfully
close to the situation where somebody may be killed. There is a
general trend toward polarization in our society. . .”
...
When I teach research ethics to the future scientists of the
world—graduate students and post-doctoral fellows—we spend a lot of
time talking about this. Not just the important party line of the
special offices at research facilities devoted to animal care:
“refine, reduce, and reuse.” But also about deeper questions: should
we do research with animals at all? With certain animals and not
others (much of basic research is done on yeast, worms, fruitflies,
and mice)? And what kinds of research (research that might cause pain
or even death, observational research, etc.)?
...
There are, after all, more than enough rich and important questions to
chew on: (1) one day—a day some (not me) believe is nigh—we will no
longer need animal models at all; we will develop artificial models
which will work as well to accomplish our goals and test our ideas for
basic knowledge, drugs, and other therapies; (2) another animal we do
a lot of testing on is ourselves, humans; if we’re going to raise
questions about research on animals, we must carefully examine
research on humans; (3) and a final irony: the more research we do on
animals, the more we discover, for better or worse, just how similar
they are to us.

--
full story:
http://www.religiondispatches.org/archive/scienceenvironment/1851/killing_one_primate_to_save_another:_the_ethics_of_animal_rights

Thursday, September 24, 2009

In Defense of Animals Wins Landmark FOIA Victory in Federal Court

USDA Forced to Disclose Records from Controversial Animal Test Lab
Huntingdon Life Sciences

http://idausa.org/news/currentnews/nr_092309.html


Washington, DC —After a seven-year court fight, including the first
trial in years involving the federal Freedom of Information Act
(FOIA), the U.S. Department of Agriculture has been ordered by a
federal judge to disclose 1,017 pages of records obtained during an
investigation of controversial toxicology lab Huntingdon Life Sciences
(HLS) to In Defense of Animals, the animal protection group said
today.

“These records will shed light on the USDA’s failure to enforce the
Animal Welfare Act,” said IDA Research Director Eric Kleiman. “Why did
the USDA, later joined by HLS, fight so hard and so long to prevent
the public from seeing these records? We’ll know within the 60 days
ordered by the Court.”

The records – 503 pages withheld in full, 514 withheld in part (with
most heavily redacted) – include test results, notes of observations
of primates involved in toxicology testing, Animal Care and Use
Committee minutes as well as necropsy reports and requests for
veterinary care from six studies.

IDA filed the lawsuit in 2002 against the USDA, but later HLS
“intervened” and also became a defendant. At trial, the USDA did not
produce a single witness; HLS had two.

The December 2008 trial, the first in years involving FOIA, resolved
the issue of whether HLS would suffer competitive harm if the records
were disclosed. These records, obtained by the USDA during its
investigation of the lab, formed the basis of the USDA’s formal
complaint against HLS, alleging multiple and grave violations of the
Animal Welfare Act (AWA). The charges included multiple counts of
failing to provide adequate veterinary care and inadequate research
oversight.

Within days of filing the complaint against HLS, the USDA settled it
with what IDA termed a “slap-on-the-wrist” fine. This was consistent
with multiple USDA Inspector General reports regarding the agency’s
lax enforcement of the AWA. The most recent, in 2005, stated that USDA
imposes “minimal” fines that “violators consider…a normal cost of
conducting business rather than a deterrent for violating the law.”

The FOIA trial came about as a result of an opinion by another judge,
who, after reviewing a sampling of the unredacted records in camera
(in private), expressed his doubt that defendants could prevail at a
trial focusing on the issue of competitive harm. This judge stated
that the USDA and HLS came “mighty close” to “’blatantly’
contradicting the record” in the case. He also noted that the USDA had
violated a prior court order by failing to produce an analysis of what
could be redacted from the records.

Kleiman noted that IDA has won multiple FOIA victories, including a
court-ordered public interest fee waiver for thousands of pages of NIH
records after IDA had proven its “dissemination methods and history
demonstrate that the disclosure will contribute to a greater
understanding” by the public. IDA has also used FOIA records to
document data manipulation and researcher misconduct (see “Drug Study
Hid Chimp Deaths,” at http://www.startribune.com/templates/Print_This_Story?sid=11617276


“This victory is the latest in a long line of IDA campaigns that often
take years,” concluded Kleiman. “No matter how long, IDA will continue
to persevere on behalf of those who cannot speak for themselves.”

The public interest law firm Meyer, Glitzenstein & Crystal represents
IDA in this case. The District Court opinion is available online at
https://ecf.dcd.uscourts.gov/cgi-bin/show_public_doc?2002cv0557-121


First Pan-African Seminar on Alternatives to Animal Experiments

A groundbreaking initiative to promote and implement replacement
alternatives across Africa begins today in Nairobi, Kenya.

The First Pan-African Seminar on Alternatives to Animal Experiments in
Education and Training is being held 23-24 September 2009 at the Kenya
Institute of Education.

Co-organised by InterNICHE and its Partner organisation the Africa Network
for Animal Welfare (ANAW), the 2-day Alternatives Seminar brings together
22 campaigning organisations from 12 African countries, InterNICHE experts
from England, Mexico, India and Egypt, and over 100 Kenyan teachers,
surgeons and government officials.

The Kenyan Minister for Wildlife and Forestry, Hon. Dr. Noah Wekesa,
opened the animal protection workshop that is being held in advance of and
in preparation of the Alternatives Seminar. In his presentation, Dr.
Wekesa appreciated the importance of pan-African events, and acknowledged
the potential of new technology and alternatives.

The Alternatives Seminar builds on the experience of InterNICHE outreach
tours and alternatives demonstrations by dovetailing the organisation’s
skills and resources with the initiatives and local knowledge of
campaigners and teachers in the host country.

Previous outreach tours have included the training of over 400 teachers in
10 cities across India, and a 5-country tour of Latin America with over 30
seminars and meetings. The InterNICHE Multimedia Exhibition at the recent
VII World Congress on Alternatives showcased a range of teaching and
training tools from the InterNICHE Alternatives Loan System. This library
is providing over 100 software alternatives, models, mannekins and
simulators for demonstration at the event in Kenya.

Following an introduction and review of the Kenyan and African situation
by ANAW Director Josphat Ngonyo and colleagues, international experts will
provide lectures and demonstrations on humane education and the process of
replacement. InterNICHE Co-ordinator Nick Jukes will introduce the range
and quality of alternatives and explain the organisation’s commitment to
the 1R of replacement to help guarantee ethical and effective acquisition
of knowledge and skills.

India’s foremost campaigner for alternatives, Snehal Bhavsar, will
describe her strategies for catalysing curricular change across the state
of Gujarat in India, including her success in achieving 80% reduction of
animal use in education. Sofia Ponce will present the vision and
activities of the Center for Animal Alternatives in Education (CAAE)
program at the University of Guadalajara in Mexico. Fawzy Elnady from the
University of Cairo in Egypt will address information and communications
technology in relation to alternatives, with a global and African
overview.

Further presentations will include the rationale for seeing caring as an
essential clinical skill which must be placed at the heart of veterinary
and medical training; the use of the POP-trainer for live laparoscopic
surgical training without animal experiments; and the use of the Biopac
Student Lab for self-experimentation as an alternative in physiology
practical classes.

InterNICHE works with teachers and producers of alternatives to encourage
the freeing of learning tools from license restrictions and limited
geographical availability. Demonstrations and hands-on experience of
alternatives at the Alternatives Seminar will therefore be followed by
distribution of resources to the participants, including freeware and
other low-cost or no-cost alternatives whose impact can now be measured
globally.

Discussion workshops will address the opportunities and challenges within
Africa and allow for sharing of experience. The talks and diverse
international perspectives will encourage the pan-African and Kenyan
campaigners to reflect on culturally-appropriate strategies for the
introduction of alternatives in their countries.

Josphat Ngonyo from ANAW said today: “We intend that the Alternatives
Seminar will empower participants to be ambassadors for alternatives in
their own countries. They will shortly have the information, resources and
support from InterNICHE for this to be achieved. The impact on Kenya will
be considerable, particularly now with government support for humane
approaches and innovative technology in education and training.”

Nick Jukes from InterNICHE added, “We applaud the Kenyan government’s
interest in humane education and are confident in the pedagogical, ethical
and economic advantages of replacement alternatives. We hope that other
countries will follow Kenya’s lead, and that the Alternatives Seminar will
play a role in facilitating the process of change right across the
continent.”


Notes:

(1) The organisation of the event has been made possible thanks to the
generous support of the Anti-Vivisection Union (South Australia), the
Doerenkamp-Zbinden Foundation (Switzerland), the Maria Norbury Foundation
(USA), and an anonymous donor (USA).

Further thanks go to the International Association Against Painful
Experiments on Animals (IAAPEA) (UK), the On Shore Foundation (USA), the
New England Anti-Vivisection Society (NEAVS) (USA) and Hope Ferdowsian
(USA).

(2) African countries represented include DR Congo, Egypt, Ethiopia,
Kenya, Nigeria, Rwanda, Sierra Leone, Somalia, South Africa, Tanzania,
Uganda and Zimbabwe.

(3) Kenyan government officials include Hon. Dr. Noah Wekesa, Minister
for Wildlife and Forestry; Dr. Julius Kipng’etich, Director, Kenya
Wildlife Service; Hon. Adan Duale, Asst. Minister of Livestock
Development; Dr. Peter Ithondeka, Director, Department of Veterinary
Services



*************************************************

Nick Jukes
InterNICHE Co-ordinator

98 Clarendon Park Road
Leicester LE2 3AE
England

tel: +44 116 210 9652
e-mail: coordinator@interniche.org

web: www.interniche.org

Thursday, September 17, 2009

4.5 Million Animals to be Spared in the EU

Groups Applaud Swift Action by EU Chemicals Agency

Brussels (16 Sept. 2009)--Animal protection groups today welcomed a
response from the European Chemicals Agency (ECHA) to their request for
clarification regarding safety testing requirements under the EU's REACH
chemicals regulation, which promises to spare approximately 4.5 million
animals from suffering and death in chemical-poisoning tests..

Animal groups--including the European Coalition to End Animal
Experiments, Eurogroup for Animals, Humane Society International -
Europe, People for the Ethical Treatment of Animals and PETA Europe and
the Physicians Committee for Responsible Medicine--wrote last month to
ECHA raising concerns about the risk of companies conducting duplicative
animal tests for some types of toxicity when registering their chemicals
under REACH. The groups' concerns arose due to the cumulative nature of
the way information requirements are listed within REACH, according to
which chemicals are required to undergo progressively more animal
testing as their production volume increases.

In particular, there was a danger that companies would conduct
'screening' tests for reproductive and general toxicity (which still
consume dozens to hundreds of animals per chemical), and would later be
required to conduct more comprehensive tests for these same effects. The
language within REACH and its guidance was ambiguous on this point.

ECHA has today issued a press statement clarifying that animal tests
need not be conducted if similar, more comprehensive tests are going to
be proposed. Companies registering chemicals that are produced in
quantities of 100 tonnes or more can therefore fulfil initial
registration requirements without performing the screening tests if they
are proposing to do more comprehensive tests later in the process.

The animal groups estimate, based on ECHA's own figures that 6,000
chemicals may fall under the relevant information requirements, that
this clarification alone has the potential to save the lives of 4.5
million animals.

The task at hand now is to make sure companies abide by this clear
instruction and do not conduct duplicative testing on qualifying
chemicals.

"We are delighted that ECHA has responded so promptly and positively to
our request and helped prevent potential duplicative testing using more
than 4 million animals. We still have other concerns regarding REACH and
its implementation, but this common sense approach is a good start."

ENDS

REACH is the EU's Registration, Evaluation and Authorisation of
Chemicals regulation.

The 13 Aug. joint letter to ECHA is available online at
http://bit.ly/8Y4T5


http://echa.europa.eu/doc/press/pr_09_13_animal_testing_carification_200 90915.pdf



More specifically, 28-day general toxicity studies and screening tests
for reproductive toxicity do not need to be conducted if 90-day general
toxicity studies or pre-natal developmental studies are proposed.

Wednesday, September 9, 2009

Pain for Dogs Doubles at Huntingdon Life Sciences;

Pain for Dogs Doubles at Huntingdon Life Sciences;
Overall HLS Experimentation Drops

Somerset, NJ - Recently obtained federal reports reveal that Huntingdon
Life Sciences use of dogs in painful experiments without anesthesia has
more than doubled, even though their overall experimental business has
dropped.

In 2008, 77 dogs were force-fed toxic substances whose side effects
caused substantial pain, without receiving anesthesia. At least 5 of
these dogs were so injured by the toxic substances that they had to be
killed. In 2007, only 30 dogs were used in experiments involving
unrelieved pain.

"The concept that dogs, no different than those who share 43,000,000
American homes, are literally poisoned inside the labs of this facility
is totally shocking," added Budkie. "This is not science; this is
nothing short of animal abuse."

However, these same reports reveal that animal activists' campaign
against the Huntingdon Life Sciences (HLS) Corporation has been
effective. Government reports filed by the company disclose a one-year
drop of 34% in animal use at the New Jersey laboratory.

2007 animal use reported to the USDA by HLS was 2143 regulated animals
(not including rats, mice etc.). 2008 animal use plummeted to 1415, a
drop of more than 1/3.

"Clearly the campaign by animal activists is having a major impact,"
said Michael A. Budkie, A.H.T., executive director, SAEN. "Anytime you
see a 1/3 drop in business in one year something is very wrong."

The USDA reports are available upon request from SAEN.

Note from WAR: Our sincere appreciation to Michael Budkie and SAEN for
obtaining and posting this information. For your convenience, we have
obtained copies of the USDA reports from SAEN and have posted links to
each of the three reports below. Just click on the links. If you have a
problem accessing the reports from the links below, drop us an e-mail
and we will send them to you as attachments.

http://war-online.org/2006HLS22-R-0040.pdf


http://war-online.org/2007HLS22-R-0040.pdf


http://war-online.org/2008HLS22-R-0040.pdf


WAR will be issuing a statement regarding the press release, along with
details about our next scheduled protests, within 24 hours.

Coming events: Mark your calendars now!

September 13, 2009 @ 2:00 pm - HLS Protests in Midtown Manhattan
September 14 - 20: Max Mara Anti-Fur Week of Action
September 24 - 27: Escada Anti-Fur Week of Action

Visit the WAR Calendar for future events:
http://calendar.yahoo.com/winanimalrights

Visit the WAR MySpace page: http://www.myspace.com/winanimalrights

Visit WAR on Facebook:
http://www.facebook.com/pages/Win-Animal-Rights/25169195791


For more info contact Win Animal Rights at: winanimalrights@optonline.net
Call: 646.267.9934 or visit the WAR website at: http://war-online.org


W.A.R. (WIN ANIMAL RIGHTS) is an independent non-profit organization not
affiliated or associated with SHAC, SHAC USA or any other group or
organization and does not conduct or incite any illegal activity. The
above information is not meant to incite or request any illegal actions
or illegal activities of any kind. If you have any questions about the
legality of any act, we encourage everyone receiving this (or the)
action alert(s) to check your local laws and ordinances before
proceeding to do anything.

Friday, August 7, 2009

Farmer who starved animals jailed

A NEW South Wales farmer has lost his challenge to a minimum 17-month jail term for his callous and persistent cruelty in letting hundreds of animals starve to death.

In dismissing Paul Hamilton's sentence appeal, Judge Ann Ainslie-Wallace said RSPCA inspectors had to kill many of the emaciated animals, deeming it too cruel to keep them alive.

"He had the money to feed them, but he did not,'' the judge said in the NSW District Court in Sydney.

In July 2008, a Wagga Wagga Local Court magistrate jailed Hamilton, 48, for a minimum of 17 months and a maximum of 26 months.

Due to a miscalculation by the magistrate, the judge adjusted his maximum term to 25 months.

The magistrate had found the farmer guilty of 132 counts of aggravated animal cruelty, 39 of failing to provide sufficient food and 19 of failing to provide veterinary care.

Referring to photos before the District Court, Judge Ainslie-Wallace said "most of the cattle were nothing but skin and bones'' and were "appallingly emaciated''.

RSPCA inspectors made regular visits to his property near Wagga between May and July 2005 after receiving complaints about stock being neglected.

The judge detailed their reports, which described seeing distressed, starving, diseased, dying or dead cattle and other animals.

Some were bellowing in pain, others had glazed or sunken eyes, and many were too weak to stand.

During one visit when 160 head of cattle were seen in an emaciated state, Hamilton was asked if he had fed them over the weekend.

"He said he could not require his employees to work seven days a week,'' the judge said.

Hamilton rejected an offer for financial help in feeding the animals.

The judge dismissed his claim that the problems would not have arisen had the council permitted him to operate a feed lot or to engage in roadside grazing.

She referred to his "persistent' ' conduct, which continued after the first RSPCA visit and after he was given a feeding schedule on the second visit.

The judge also referred to his "callous indifference' ' to his responsibilities and to the fact that he lived and worked on the property, which meant he could see what was happening.

Noting character references before the court, the judge said: "That the applicant is well regarded by business associates does not mitigate the seriousness of the offences.''

She referred to other convictions, including contravening the Animal Research Act, and animal cruelty counts in Victoria.

Orders that he is banned from owning animals for 10 years and must pay the RSPCA's $250,00 legal bill remain.

The judge earlier noted Hamilton was now bankrupt.

She backdated his sentence to begin on April 29, 2009, to take into account time he has already spent in custody.

http://www.news.com.au/heraldsun/story/0,21985,25896563-5005961,00.html

Wednesday, July 29, 2009

Dr.Hadven Trust-Newsletter for July



'Roadmap to Replacement' needed, says the DHT, following 14% rise in animal experiments
The Dr Hadwen Trust was quick to respond to new Home Office statistics published July 21st that reveal a substantial rise in Britain's animal experiments. With 2009 marking the 50th anniversary of the birth of the 3Rs* (replacement, reduction and refinement of animal experiments) , far greater progress to replace animals with alternatives could and should have been made but instead animal numbers are now as high as they were in the late 1980s. The Dr Hadwen Trust said this was "a wake-up call moment for policy makers" and immediately wrote to the Prime Minister Gordon Brown, Conservative leader David Cameron, Lib Dem leader Nick Clegg and Green Party leader Dr Caroline Lucas, to seek political commitment to devising a national 'Roadmap to Replacement' .Animal research statistics 2008 at a glance
39% increase in animal experiments sinceLabour came to power in 1997
3.656 million animal experiments
3.583 million animals
14% rise in animal experiments
16% rise in experiments on GM animals
16% rise in monkey experiments
17% rise in cat experiments
9% rise in mice experiments
82% rise in experiments on amphibians
85% rise in fish experiments
95% rise in pig experiments
Decreases in use of dogs (-18%), rabbits (-13%)Click here to read our press release reaction...
* What are the 3Rs?In 1959 two British scientists, William Russell and Rex Burch, were the first to define the concept of the replacement, reduction and refinement of animal experiments, now adopted throughout much of the world and incorporated into legislation. Whilst the Dr Hadwen Trust's work focuses on the single 'R' of the replacement of animals, we recognise the enormous significance of the 3Rs concept in stimulating work on non-animal methods over the last fifty years.
DHT tells House of Lords Committee: EU needs new strategic vision to replace animals
In June the Dr Hadwen Trust's science policy team presented oral evidence to the House of Lords EU Committee as part of its consultation with experts on the Directive 86/609 proposals. The DHT told the Committee that policy makers must embrace the vision of a world where animal experiments have either been fully replaced or are prohibited, and that as a solutions-led charity the Dr Hadwen Trust works to find the science to achieve that vision. Once again we promoted the establishment of an EU Centre of Excellence in Alternatives, incorporating a new strategic vision of science for the future. We believe that establishing an EU Centre would be one of the most significant achievements of the revised Directive, setting strategic goals for replacement science across all areas of animal use. The Committee's newly published interim conclusions indicate that it agrees.Find out more...
7th World Congress on Alternatives
The Dr Hadwen Trust's science and policy team is gearing up for the 7th World Congress on Alternatives in Rome. This is the key event of the year attended by non-animal research scientists and experts from around the globe, providing a unique forum to meet, exchange ideas and create opportunities for international collaborations. We are delighted that nineDr Hadwen Trust-funded researchers will be presenting their cutting-edge replacement work at the Congress this year.Find out more...
Ricky Gervais, Joanna Lumley and other stars join cyber march for humane science
Comedian Ricky Gervais, actress and DHT Patron Joanna Lumley OBE and rockers Brian May CBE and Chrissie Hynde, have joined tens of thousands of people taking part in the Make Animal Testing History virtual march to Brussels to update the EU's 20-year old law on animal experiments. Click here to see the celebrity avatars cheering on the marchers; click each avatar to see what they have to say."With all the non-animal techniques available now and in the future, we really don't need to hurt animals to make medical progress."Ricky Gervais
Dr Hadwen Trust research wins non-animal replacement prize
Dr Hadwen Trust-funded researchers studying breast cancer have won a prestigious non-animal replacement prize at an event hosted by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and held at the House of Lords. Our researchers at Leeds Institute of Molecular Medicine and Queen Mary's, University of London, constructed athree-dimensional model of human breast cancer in the test tube using human cells.Find out more...
Spotlight on life-saving research without animal suffering
Huntington's disease: Huntington's disease (HD) is an incurable inherited genetic disorder that affects the nervous system. Currently, much research into HD is conducted on monkeys, pigs and rodents injected with toxic chemicals or genetically modified to mimic symptoms. However, results have been conflicting and there have been no major therapeutic advances so far. Our research at Sheffield University aims to produce a new non-animal model of HD using human skin cells from HD patients. This would be far more useful for understanding the underlying cellular mechanisms that contribute to the disease and enable fast screening of potential drugs.
© Dr Hadwen Trustfor Humane Research18 Market PlaceHitchinHertsSG5 1DSUnited KingdomRegistered charity 261096
To subscribe to this e-newsletter click here.Privacy Policy - The Dr Hadwen Trust is committed to protecting your privacy and security. Whenever you provide personal information, we will treat that information in accordance with this policy, current UK Data Protection legislation and internet best practice. This information will only be used by the Dr Hadwen Trust.

> Latest news


> Science Room


> Join Us

Microlungs


Artificial "microlungs" grown using human lung tissue, could replace animal testing for lung toxicity for pharmaceuticals, chemicals and cosmetics. Find out more...


easyfundraising


Shop with easyfundraising for clothes, CDs, gifts and more from major brands, select the Dr Hadwen Trust as your cause and every purchase means a donation for us.


Donate now


At the Dr Hadwen Trust, we don't just hope for a world without animal experiments, we're making it happen. If you'd like to be a part of our mission to replace animal research with alternatives, please make a donation today...


JustGiving


If you're a fabulous fundraiser walking, climbing or cycling to raise funds for the Dr Hadwen Trust, set up a sponsorship page at JustGiving.


Welcome Candida and Adina


Dr Candida Nastrucci (left) is our new Science and Communications Officer. A scientist holding a DPhil in Clinical Biochemistry from the University of Oxford, Candida has expertise in Applied Molecular Biology and Biotechnology with an MSc from University College London (UCL) and a BSc. Hons. in Biochemistry with Biotechnology, from the University of Manchester Institute of Science and Technology (UMIST). She also has experience in post-doctoral research and teaching in academia, as well as animal charity work.


Adina Farmaner (right) has joined the Dr Hadwen Trust team as Fundraising Director. Adina brings with her 15 years experience working for charities such as Christian Aid, the RSPCA and Amnesty International UK, and she now hopes to unite her extensive fundraising experience with her passion for the DHT charity of which she has been a supporter for over 10 years.


The Dr Hadwen Trust is the UK's leading non-animal medical research charity, benefiting people and animals. If you are not already a member, join us today and help us put your ethics into action with vital medical research to replace animal experiments, like our Huntington's disease research project. You'll receive our quarterly members' magazine Alternative News as well as other exclusive benefits. With your help we can stop the suffering - thank you.

============ ========= ========= ========= ========= ========= =====
*Vivisection is a ‘costly distraction’*

http://www.scienceblog.com/cms/ blog/7769- why-do-we- need-do-animal- experiments- part-1-drug- discovery- 22800.html# comment-
Blog. 8 July 2009.
Animal experiments are a costly distraction in drugdevelopment.Despite extensive tests in animals, 92% of all potential newdrugs fail in clinical trials, usually becasue they do notwork or are unsafe, according to a white paper by the US FDA(Innovation or Stagnation: Challenge and Opportunity on theCritical Path to New Medical Products, 2004). In no other areaof science is the mantra repeated that a decades-oldtechnology is the best we have & will ever have!'The reason we use animal tests is because we have a comfortlevel with the process . . . not because it is the correctprocess, not because it gives us any real new information weneed to make decisions.' Melvin E. Andersen, director,computational systems biology, Hamner Institutes for HealthSciences, USA (quoted by Gaul, Washington Post, Saturday,April 12, 2008; Page A01).Intriguingly, a US National Research Council reportcommissioned by the US Environmental Protection Agency(Toxicity Testing in the 21st Century: A Vision and aStrategy, 2007) identified an urgent need to move from slow,expensive animal tests to more modern, more human-relevantmethods using human cells & tissues and computer programmes.The authors expected the 'paradigm shift' away from animaltests which they advocated to encounter resistance, astoxicological testing practices are 'deeply ingrained' andpressure to maintain the status quo is strong. Speaking toreporters at an American Association for the Advancement ofScience conference in 2008, after the launch of a tripleagency initiative to realise the goals outlined in the report,Christopher Austin, Director, US National Institutes of HealthChemical Genomics Center, said that 'Traditional animaltesting is expensive, time-consuming, uses a lot of animalsand from a scientific perspective the results do notnecessarily translate to humans. It’s a bold, ambitious thingto try to do but our goal is to eliminate animal use intoxicology in ten years.' More information about theinitiative can be found in Collins et al, Science, 319,906-907.Experts from academia & industry gathered at the Speed &Safety in Drug Discovery conference held at the Royal Societylast November were enthusiastic about the ability of thelatest in vitro, in silico and safer first-in-man technologiessuch as microdosing & microdialysis to out-perform thetraditional animal-based tests currently required by drugregulators (www.drugtestingcon ference.com) . They were alsovery supportive of an initiative to identify the best means ofpredicting human side effects. This could be achieved bytesting a panel of drugs for which both human and animal dataare already available in a battery of human biology-basedassays. The three data sets could then be compared to seewhether the human biology-based assays identified more of theeffects of drugs in humans than were identified by the animaltests. This comparison is called for by the Safety ofMedicines (Evaluation) Bill 2009.More information about new technologies in drug safety testingcan be found in our short film, Safer Medicines, freelyavailable on our website: www.safermedicines. org.Dr Margaret Clotworthy, Science Consultant, Safer MedicinesTrust.www.safermedicines. org/
"Tests on animals have led to around 100 drugs being thought potentially useful for stroke; not one has proved effective in humans. You don't need to be a balaclava-wearing animal rights activist to question the value of animal studies in this area of medical research." TheFirstPost. 25 January 2007.============ ========= ========= ========= ========= ===

"The ARISE Campaign: Animal Replacements Innovate Scientific Experimentation"

Stuart Chaifetz sent a message to the members of The ARISE Campaign: Animal Replacements Innovate Scientific Experimentation.
Subject: The New ARISE Blog 7/24/09
Hi everyone,Here is our latest blog. Check out the site for working links to the mentioned articles: http://www.facebook.com/l/
http://arisenj.blogspot.com/
Thanks!
And if you like what we are doing, please spread the word!Stuart ChaifetzProgram Director, the ARISE Campaign (Animal Replacements Innovate Scientific Experimentation) In the spirit of the Summer movie season, and its long history of producing sequels and trilogies, I would like to offer a third and final take on stories of research ‘breakthroughs’ being front page news, while failures are either never reported, or are dumped into the business section (grab a keg of soda and a garbage bag full of popcorn that cost more than the computer I am writing on if you really want to get that movie theater experience while reading this).In the course of my research on this issue, I found one exception to the rule that is stated above: For the first and perhaps last time, in May of 1998, scrutiny was poured over a front page story that over-promoted a supposed cure for cancer.The story “Cancer Drugs Face Long Road From Mice to Men” - published in the Los Angeles Times, May 6, 1998, was a direct response to this story - “HOPE IN THE LAB: A special report.; A Cautious Awe Greets Drugs That Eradicate Tumors in Mice,”which was printed on the front page of the NY Times three days earlier.There were two things that appear to have set off the counter-reaction to the NY Times story; a massive rush of people wanting to get the ‘cure,’ which didn’t exist, and the fact that the reporter who wrote the story created a possible conflict of interest by trying to get a book deal on it the next day. The Times itself was forced to cover the scandal:“...Peter Osnos, the publisher of Public Affairs Press, said: ''When a reporter writes a story that 24 hours later turns into a book proposal for which they're going to be paid a ton of money, that calls into a question the story they've written to begin with.”The LA Times story covering the controversy was something short of miraculous, for, once the glamor was lifted from the original article, a hard and honest look was finally taken regarding how cures in animals do not translate to cures in humans:“"The history of cancer research has been a history of curing cancer in the mouse," said Dr. Richard Klausner, director of the National Cancer Institute. "We have cured mice of cancer for decades--and it simply didn't work in humans."Recent medical history is rife with stories of cancer "cures," such as interferon, interleukin and taxol, that produced exciting results in animals and later proved disappointing in humans.Dr. LaMar McGinnis, an oncologist and medical consultant to the American Cancer Society, agreed. "We thought interferon was 'chicken soup' in the early '80s," he said. "I remember how excited everyone was; it seemed to work miracles in animals, but it didn't work in humans."”“"People do not understand how very far off this [clinical trials] is; these proteins are very difficult to make . . . and we are working very hard to make the human versions," Klausner said. "The mouse versions don't work in humans."”These statements are devastating to the pro-animal research lobby, but the question is this; eleven years after the NY Times debacle, has the media learn its lesson? In my opinion, no. Unfortunately, we still see screaming headlines telling us a cure for this disease or that one is just around the corner. And while that drives interest and support for research higher, these hopeful rays of light flash, fade, then dissolve into the darkness and reality that is the failure of animal research.

Saturday, July 25, 2009

Scientific assessment of chemical's toxicity - 28 chemicals tested

Scientific assessment of chemical's toxicity - 28 chemicals tested
with toxicogenomics



http://www.antidote-europe.org/substances_gb.htm




Scientific assessment of chemical's toxicity
28 chemicals tested with toxicogenomics

Introduction

The aim of this work is to introduce a method that is considered reliable
for assessing the toxicity of chemical substances. This goal of safety for
human health cannot be achieved through the use of standard toxicology
methods, which are still largely based on animal experiments. No animal
species is a biological model for another species, including man. This was
clearly demonstrated in the second half of the 20th century's discoveries in
the field of genetics. We can now define a species in terms of its
reproductive isolation which results from the fact that genes and
chromosomes are unique to each species and hence preclude reproduction
between different species. Genes determine protein synthesis and biological
functions. As any given species has a unique set of genes, it follows that
those biological functions will be species-specific.

Pennicillin kills guinea pigs whereas it has saved millions of humans ;
aspirin can cause birth defects in rats or dogs whereas this has not been
observed in humans. Many more examples illustrate the fact that no animal
species is a reliable model for another. Claude Bernard, the physiologist
who, in the 19th century, promulgated animal experiments as the main source
of knowledge for human medicine, stressed the similarities between animals
and humans, rather than the differences. He also justified his use of
animals on ethical grounds, as wanting to avoid experiments that could harm
humans.

We are now in the 21st century and possess many non-invasive methodologies
for the study of human medicine. Toxicological studies can be performed on
cultured human cells. In addition, for the past 15 years, we also possess
powerful new tools with which to monitor cells exposed to a given chemical -
DNA chips. These chips can reveal which genes are active in a cell at a
given time, even as soon as 24 hours after the cells have been exposed to
the test chemical. Knowing the function of these genes, we can observe the
response of the cell to the chemical and whether this response drives the
cell towards a pathological state. Toxicogenomics is the study of the genes
expressed following exposure to a chemical.

Antidote Europe has developed a novel approach to toxicogenomics by using
minituarized DNA chips, in combination with sequential exposure of two
different cell types, approximating what would occur in a whole body. We
have termed this approach "Scientific Toxicology Program" (STP) and what
follows are the results of 28 substances tested according to the STP.

Selection of test substances

France is the second largest consumer of pesticides in the world. One
hundred and fifty thousand people a year die in France from cancer. A
further 600,000 persons suffer from Alzheimer's disease and, in common with
other European countries, 15% of couples are infertile. Several renowned
researchers and medical scientists have pointed out that the widespread use
of chemicals is very likely the main cause of these shocking health
statistics. Greenpeace and the WWF have shown that dozens of chemicals are
present in the air we breathe in our homes. Worse still, chemicals in the
blood of pregnant mothers are 'off-loaded' on to the unborn foetus in the
womb. Yet, chemical manufacturers maintain that the link between chemical
use and disease has not been established.

In 2001, the European Commission launched the REACH (Registration,
Evaluation and Authorization of CHemicals) project, claiming that little or
no safety data existed with respect to almost 100,000 chemical substances
produced by industry. Following mounting pressure from manufacturers, this
number was subsequently reduced to 30,000 chemicals.

While acknowledging the need for such a project, Antidote Europe cautions
against the use of unreliable test methods for assessing toxic risk.
Classical toxicological methods still largely rely on animal experiments,
which, as we have explained, are not reliable for humans. Instead, we urge
the European Commission to incorporate STP as an integral part of its
testing strategy, based on human exposure data. Many observations have been
made following occupational or accidental exposure to chemicals. This should
be employed as a reference with respect to both the toxicity of these
chemicals and as a standard for the validation of relevant toxicological
methods. Since our aim was not to present the regulatory authorities with
data of unknown chemicals but simply to demonstrate the validity of STP, we
selected 28 chemicals already known or suspected of being toxic. We
therefore selected 15 pesticides (abamectin, aldicarb, aldrin, carbaryl,
chlorpyriphos, dicofol, fenazaquin, fipronil, heptachlor, lindane,
methoxychlor, paraquat, permethrin, phosmet and rotenone), 2 food additives
(benzoic acid -E210- and quinoline -E104-), 5 cosmetic ingredients
(3-aminophenol, 4-aminobiphenyl, 2-butoxyethanol, benzophenone-3 and propyl
paraben -E214-), 1 prescription drug (acetaminophen -paracetamol-) and 5
additional substances commonly used in industry (1,4-dioxane, acetonitril,
acrylamide, bisphenol A and ethylene glycol). Some of these substances are
multi-purpose. Although some of the pesticides have been banned in many
European countries, they may still be present in our environment and in our
water supply, thereby contaminating our bodies.

What is the STP ?

The first report on STP was published in Biogenic Amines, 2003, vol. 18, pp
41-54. STP is based on human cell cultures, DNA chips and knowledge of
genetics.

Culturing human cells has been routine in labs since about 1930. Some
centers, especially in Germany, the UK and the US, keep many different cell
lines obtained from human tissues and organs. These cells lines are
commercially available. In spite of being cancerous cells, their
characteristics are well known and they are used as biological models for
research worldwide. Our study used HepG2 liver cells and SH-SY5Y neuronal
cells. Once the culture box was covered by one layer of cells (a monolayer
of cells), the chemical to be tested was introduced and left in the culture
medium for 24 or 48 hours, at two different concentrations.

We chose liver cells because the liver, with its detoxifying function, is
crucially in contact with all chemicals circulating in the blood, and will
metabolize these chemicals in order to facilitate their elimination,
although this metabolism can result in substances becoming even more
dangerous than the original, depending on the enzymatic capability of the
liver. It is important to note that the enzymatic capability can differ
significantly between different animal species, which is one of the reasons
for the failure of animal-based toxicology with respect to humans. We chose
neuronal cells because many insecticides target the nervous system of their
victims and wanted to observe this effect on human cells.

A novel idea of our scientific team was to expose liver and neuronal cells
sequentially rather than in parallel, thus approximating the whole body
physiological response, in which the nervous system and other tissues and
organs are exposed to the metabolites circulating in the blood once the
liver has modified the original substances. And indeed we observed that some
of the tested chemicals did not elicit much response from the liver while
they (or rather their metabolites) significantly affected the neuronal
cells.

Another novel idea was to construct minituarized DNA chips containing 6
families of genes known to be implicated in the 6 metabolic pathways we had
selected for our study. These pathways were already known for their
association to particular diseases. Extensive literature already exists
regarding the role of each of these genes in normal cell metabolism, cycle
and function, as well as in pathological states. In contrast with the huge
number (many thousands of genes), expensive and time-consuming processes of
DNA chips developed in the US, for example, our cost-effective and very easy
to process minituarized DNA chips provide a key solution to the problem of
dealing with large automated platforms capable of testing tens of thousands
of substances (and many of their combinations) in reasonable time and cost
frames.

Our DNA chips contained 51 genes comprising 6 families, and designed for the
study of :

1. Cell stress : 5 genes for monitoring the response to oxidative stress
(GSS, GPX1, SOD1, GSTM3 and EPHX1), 2 genes implicated in the survival of a
cell in a stress situation (TRPM2 and HSPA9B) and 2 genes implicated in the
inflammatory response (PTGS2 -Vioxx's target- and NOS2A). If these genes are
elicited following the introduction of the substance to the culture medium,
it means the cell is under duress, and making attempts to repair cell
damage. The cell may subsequently 'commit suicide' if it cannot cope with
the damaging effects of the substance. According to the kind of damage and
if systemic mechanisms are not available for repair, exposed individuals
could develop different diseases : cancer, due to free radical activity,
inflammation or auto-immune disease, etc.

2. DNA damage : 3 genes implicated in DNA repair (RAD50, RAD51 and NFKB1), 3
genes preventing cell cycle (cell life and reproduction) following damage
(CDC25C, CDK4 and CDKN1) and 3 genes triggering apoptosis (cell death) if
the damage is not repaired (APAF1, ATM and BAX). If these genes are
themselves impaired, cells with damaged DNA will eventually grow and
multiply, resulting in cancer or developmental abnormalities, for example,
if systemic repair mechanisms are not available.

3. Cell cycle control : DNA replicates before cell division gives birth to
two cells, each receiving one copy of the original DNA. Many proteins have
crucial roles in the accurate and quality control of DNA replication as well
as in authorizing and controlling the progression of the cell cycle from
step to step. Our chips harboured 2 genes controlling cell proliferation
(FOS and JUN) and 7 genes implicated in stopping cell division and apoptotic
signal (BCL2, GADD45A, MDM2, TP53, EGF, PPARA and TUBA1). Abnormal
expression of these genes has been observed in cancer.

4. Neurotoxicity : 8 genes implicated (but not exclusively) in nerve
transmission and nervous system development (ACHE, CTSB, DRD2, TH, BZRP,
THBS1, HOXD1 and ROBO1). Abnormal expression of these genes, in the absence
of compensating mechanisms, could lead to neurological or even psychiatric
disorders, or malformations of nervous, muscular or cardiac systems if gene
expression is affected during foetal or early childhood development.

5. Hormonal response : ranging from glycaemia to reproduction, hormones
regulate many physiological functions. We have selected 10 genes under
hormonal control (TFF1, CTSD, PGR, RAN, AR, CREB1, ESR1, CALR, CYP19A1 and
ALB). Some of these genes code for steroid hormone receptors and their
deregulation could explain some of the increase in cases of genital
malformation, reduced male fertility and even breast or prostate cancer.

6. Protein conformation : the tridimensional structure of proteins is
crucial for their ability to perform their function. Correct amino acid
sequence but wrong folding is thought to lead to accumulation of non
functional proteins contributing to conformational diseases such as
Alzheimer's, type I diabetes, etc. Our chips harboured 6 genes implicated in
quality control of newly synthesized and cell loading of proteins (HSPA5,
XBP1, ATF6, ERN1, C12orf8 and A2M).

Results

Full results are available on our website or upon request from Antidote
Europe. Here, we present a brief summary of the reactions elicited by the
tested chemicals.

1. 1,4-dioxane : 3 out of the 6 marker families were impaired in liver
cells, all 6 families were impaired in neuronal cells, especially the cell
stress markers. This substance can lead to all 6 of the pathological
pathways explored.

2. 2-butoxyethanol : 41 of the 51 genes present on our DNA chips were
significantly repressed (for some of them, gene expression was reduced a
hundred-fold). All studied cellular functions were severely compromised in
both cell lines.

3. 3-aminophenol : 36 of the 51 genes were repressed, ten-fold for some of
them. All studied cellular functions were compromised in both cell lines.

4. 4-aminobiphenyl : 4 genes were overexpressed in liver cells (markers for
cell stress, DNA damage, cell cycle control and hormonal response) ; 25
genes were repressed in neuronal cells, in all 6 pathological pathways
explored.

5. Abamectin : 44 of the 51 genes were strongly repressed, a hundred-fold in
some cases. 27 genes were repressed in both cell lines. This insecticide
(targeting GABA synapses) has an unequivocal pathological potential.

6. Acetaminophen (paracetamol) : 30 genes were repressed quite strongly, 2
genes were overexpressed, affecting all cellular functions under study in
both cell lines.

7. Acetonitril : 2 genes were repressed and 3 overexpressed in liver cells
(markers for cell stress, DNA damage, cell cycle control, neurotoxicity and
hormonal response). 15 genes were repressed in neuronal cells, affecting all
studied cellular functions.

8. Benzoic acid (E210) : 38 of the 51 genes were repressed, significantly in
some cases. All studied cellular functions were disturbed in both cell
lines.

9. Acrylamide : 3 genes were overexpressed, 30 were repressed, significantly
in some cases. In neuronal cells, the response was mainly observed after
exposure to the highest dose. In contrast, liver cells were also affected at
low doses. All studied functions were affected in both cell lines.

10. Aldicarb : expression of 20 genes was affected in both cell lines and a
further 24 genes were affected in one or the other cell line, totalling 44
markers elicited. All studied cellular functions were affected in both cell
lines.

11. Aldrin : 14 genes were affected in liver cells, mainly overexpressed. 11
genes were affected in neuronal cells, of which, 2 were dramatically
overexpressed. All studied cellular functions were affected in both cell
lines, with very different reactions for each gene.

12. Benzophenone-3 : 2 genes were repressed (cell stress and neurotoxicity)
and 1 overexpressed (DNA damage) in liver cells. 16 genes were repressed in
neuronal cells, affecting all studied functions in this cell line.

13. Bisphenol A : 1 gene was repressed in liver cells after exposure to high
dose. 7 genes were overexpressed in liver cells after exposure to low dose.
20 genes were repressed in neuronal cells, affecting all studied functions.

14. Carbaryl : 4 genes were overexpressed and 7 were repressed in liver
cells, affecting all studied functions in this cell line. The effect was
dramatic on neuronal cells, in which 48 genes were significantly repressed
(a hundred-fold or more).

15. Chlorpyriphos : expression of 42 genes was affected in both cell lines
and a further 7 genes were affected in one or the other cell line, totalling
49 markers elicited out of the 51 harboured by our DNA chips. Genes were
repressed except for one neurotoxicity marker, which was overexpressed in
neuronal cells.

16. Dicofol : only one gene (a neurotoxicity marker) was slightly repressed
in liver cells. But 41 genes were repressed in neuronal cells, affecting all
studied functions in this cell line.

17. Ethylene glycol : 29 genes were repressed in liver cells, 48 genes were
repressed in neuronal cells, affecting all studied functions in both cell
lines.

18. Fenazaquin : 22 genes were strongly repressed in liver cells, 11 genes
were significantly repressed in neuronal cells, affecting all studied
functions in both cell lines.

19. Fipronil : 2 cell stress markers and 2 DNA damage markers were affected
in both cell lines ; 1 neurotoxicity and 1 hormonal response marker were
repressed in liver cells ; 1 cell cycle control, 2 hormonal response and 1
protein conformation marker were repressed in neuronal cells.

20. Heptachlor : 1 DNA damage marker was overexpressed in liver cells. 17
genes were repressed in neuronal cells, affecting all studied functions
mostly after low dose but long exposure time.

21. Lindane : 11 genes were repressed in both cell lines and another 32
genes were repressed in one or the other cell line, totalling 43 markers
repressed, thus affecting all studied functions in both cell lines.

22. Methoxychlor : 20 genes were affected in both cell lines and a further
23 genes were repressed in one or the other cell line, totalling 43 markers
elicited, thus affecting all studied functions in both cell lines. Except
for 1 overexpressed neurotoxicity marker in liver cells, fairly significant
repression was observed for all the other markers.

23. Paraquat : 46 genes were strongly repressed in both cell lines,
affecting all studied functions. Most dramatic effects were seen for DNA
damage and cell cycle control markers. For the long time exposure, most of
the elicited markers in neuronal cells were repressed a hundred-fold.

24. Permethrin : 7 genes were affected in liver cells, with respect to cell
stress, DNA damage and hormonal response functions. Neuronal cells were more
significantly affected, with 33 genes repressed, especially after long
exposure. All studied functions were affected in neuronal cells.

25. Phosmet : 2 genes wre overexpressed and 11 repressed in liver cells. 41
genes were significantly repressed in neuronal cells. All studied functions
were affected in both cell lines.

26. Propyl paraben (E214) : 6 out of 6 studied functions were affected in
both cell lines. Neurotoxicity markers were only slightly elicited in liver
cells.

27. Quinolin (E104) : 5 out 6 studied functions were affected in liver
cells, with most of elicited markers repressed two-fold. All studied
functions were affected in neuronal cells.

28. Rotenone : 29 genes repressed in liver cells, 27 in neuronal cells. The
most dramatic effects (hundred-fold repression) were observed on neuronal
cells after long exposure.

These being the first studies done with the STP, we do not have all the keys
for translating laboratory observations into specific prediction of disease
risk. However, we clearly see that each substance elicits a specific
response. In order to accurately hypothesize possible effects on the
individual, many parameters would have to be taken into account. For
example, water-soluble substances will easily circulate in body fluids and
be quickly eliminated whereas lipid-soluble ones will be stored in
adipocytes (fat cells) and can also remain in the lipidic sheaths of the
neuronal cells, thus posing a risk to potential target cells and tissues
over long periods of time. Whereas a substance capable of damaging the
central nervous system must cross the blood-brain barrier, a xenoestrogen
will easily reach its target simply by being transported in the blood, as is
the case with steroid hormones.

Effects already observed in humans

Clues about the validity of STP can be found by considering what is known
about the tested substances following human accidental or occupational
exposure. According to the International Agency for
Research in Cancer :
- workers exposed to 4-aminobiphenyl have developed bladder cancer
- urinary tract cancer has been observed in acetaminophen users in Australia
; others have reported hepatotoxicity of this drug
- nervous system problems have been observed in workers exposed to
acrylamide
- aldicarb has already been shown to induce DNA damage and mutations in
human cultured cells
- chromosomal aberrations have been induced by aldrin in cultured human
lymphocytes (white blood cells) ; aldrin inhibited intercellular
communication in human cell systems
- slight excess of lung cancer cases was observed in workers exposed to
heptachlor
- 4 cases of leukaemia were reported in men exposed to lindane ; cases of
aplastic anaemia have also been associated with exposure to lindane.
- P. Darbre et al have found parabens in tissue samples from breast tumors
and state that these chemicals are known xenoestrogens (J Appl Toxicol,
2004, 24, 1-4).
- Professor Charles Sultan states, after a study on exposure to pesticides,
that babies born to farmers have twice the normal risk of presenting genital
malformations.

All of this data is a small part of a much bigger picture since cancer,
neurological disorders and most of other diseases under consideration may
have very long latent periods of onset, and therefore the link between the
triggering substance and the disease will not be established as exposure
will have ceased long before the appearance of the first symptoms. However
initial these observations, they are nevertheless consistent with what could
be hypothesized as the chemical's effects on the basis of our STP results.

We can improve STP

The results presented here are the very first obtained with STP based on
limited resources. Many improvements are possible.

1. Cell types. For substances likely to be absorbed through inhalation or
feeding, lung and gut cells should be tested as these organs will be exposed
first. Blood and kidney cells should also be tested routinely. For very
important chemicals (prescription drugs, for example), STP could be a first
step before microdosing tests in healthy volunteers and could give more
valuable information than animal tests, after which only 1 drug out of 12
makes it to the market. STP is potentially a more powerful tool than QSAR
and other simulations since STP is not a simulation, but a direct
observation of what is taking place in human cells.

2. Markers. The human genome contains about 25,000 genes. About 1100 are
known to respond to chemical exposure. Although the 51 set selected for our
DNA chips have key functions in the processes we intended to study, there is
still room for a greater number of markers on chips designed to monitor
unexpected effects of substances.

3. Time and dose. Our results represent a snapshot of the state of gene
expressions 24 and 48 hours after the introduction of the test substance
into the culture medium. It would be interesting to observe more snapshots
at shorter, intermediate and longer periods of exposure. The same is true
for concentrations of test compounds, especially for suspected xenoestrogens
as the endocrine system is sensitive to infinitesimal doses.

Conclusion

As imperfect as it is, STP has already proven much more reliable that
animal-based toxicology and should replace it at once. Carcinogenicity
tests, which take several months and yield unreliable results in rodents,
can be performed in a few days with STP, in conjunction with other tests
(neurotoxicity, immunotoxicity, acute toxicity, etc.), thereby sparing the
lives of countless animals. STP has the advantage of dealing with human
genes, thus allowing the identification of sensitive individuals or groups
of individuals to a particular substance, based on our knowledge of human
polymorphism, unique to humans and not predictable through animal-based
toxicology.

With STP, automatization and optimisation of tests is possible at the very
early stages of a new chemical's development, thus allowing early screening
and disqualification of dangerous or ineffective substances, with consequent
gain of time and money. The short test times employed by STP would be able
to cope with the original 100,000 chemicals initially included in the REACH
project, and even many combinations of molecules (not feasible using on
animals), in a reasonable period of time (much less than the 12 years
considered by the European Commission for only 30,000 substances with the
current means).

With toxicogenomics programs receiving substantial funding in the US and
Japan, Europe should seriously consider allocating resources to improve STP
whose novel approach could put the EU at the cutting edge of this promising
new technology. These techniques are likely to become the standard in the
coming years, and manufacturers should help to implement them rather than
spending yet money on useless animal-based tests - and before public opinion
loses confidence in an industry that avoids using the best available
technology to assess the safety of its products.

http://www.antidote-europe.org/index.htm

Friday, July 17, 2009

Vivisection Animal Breeder Global Week Of Action

Without vivisection breeders, the vivisection industry would struggle to exist.


Each day these sick companies operate simply to mass produce animals and send them to horrific deaths inside labs across the world. Time to stand up and fight!


Please organise demonstrations against your nearest vivisection breeder for a Global Week of Action which will be taking place Monday 21st to Sunday 27th
September 2009.


Demos will be happening across the world against vivisection breeders - go to: http://www.shac.net/AnimalBreeders to see the website listing targets, groups and advertised demos. Contact us: info@shac.net if you are organising a demo against a vivisection breeder.


Other action
If you can't make any of the demonstrations, why not support the national demo and politely write to Highgate Farm and ask them to stop breeding animals for vivisection:

George W Douglas
Highgate Farm
Highgate lane
Normanby-by-Spital
Market Rasen
Lincolnshire
LN8 2HQ
UK


01673 878 232


Please look at: http://www.shac.net/OperationLiberation for more information about the UK demo at Highgate Farm.


Start arranging transport and get in touch for more information, transport arrangements or querries about the UK demo or the Global Week of Action.


Tel: 0845 458 0630 | E-mail: info@shac.net | Web: www.shac.net

Saturday, July 11, 2009

(US/ca) Ruling Calls for Publication of Animal Research Information

A recent court decision will require the U.S. Department of
Agriculture to publish more information about animal research
performed by UC Berkeley and other research institutions.

However, the ruling is unlikely to have an effect on campus research
operations, according to campus officials.

A July 1 ruling brought an end to a 2005 lawsuit filed by the Humane
Society of the United States, which charged that the USDA violated the
Freedom of Information Act by redacting information from reports
required by the Animal Welfare Act.

"We're very happy with the settlement and looking forward to having
more information readily available," said Kathleen Conlee, the
society's director of program management for animal research issues.

Passed in 1966, the welfare act requires researchers to provide
warmblooded animal with humane living conditions as well as anesthesia
during surgery and recovery time afterwards. The act does not apply to
birds, rats or mice that are bred for research.

--
full story:
http://www.dailycal.org/article/106043/ruling_calls_for_publication_of_animal_research_in